Author

G. Gasper

OpenAlex ID: A5126234334

Abstract PS5-07-30: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation

2026 · M. P. Goetz, S. A. Wander, et al. · Clinical Cancer Research

Works count: 1

Citation count:

H-index:

I10-index: